MA55219A - Nanoparticules lipidiques non actives avec adn dépourvu de capside, non viral - Google Patents
Nanoparticules lipidiques non actives avec adn dépourvu de capside, non viralInfo
- Publication number
- MA55219A MA55219A MA055219A MA55219A MA55219A MA 55219 A MA55219 A MA 55219A MA 055219 A MA055219 A MA 055219A MA 55219 A MA55219 A MA 55219A MA 55219 A MA55219 A MA 55219A
- Authority
- MA
- Morocco
- Prior art keywords
- capsid
- free
- viral dna
- lipid nanoparticles
- active lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
- A61K48/0033—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being non-polymeric
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962814460P | 2019-03-06 | 2019-03-06 | |
US201962857557P | 2019-06-05 | 2019-06-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA55219A true MA55219A (fr) | 2022-01-12 |
Family
ID=72337571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA055219A MA55219A (fr) | 2019-03-06 | 2020-03-06 | Nanoparticules lipidiques non actives avec adn dépourvu de capside, non viral |
Country Status (8)
Country | Link |
---|---|
US (1) | US20220175968A1 (fr) |
EP (1) | EP3934700A4 (fr) |
AU (1) | AU2020232790A1 (fr) |
CA (1) | CA3131130A1 (fr) |
IL (1) | IL286026A (fr) |
MA (1) | MA55219A (fr) |
SG (1) | SG11202109426YA (fr) |
WO (1) | WO2020181168A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108728491B (zh) * | 2018-06-21 | 2022-08-26 | 陕西杆粒生物科技有限公司 | 一种广谱抗凋亡杆状病毒表达载体 |
IL299925A (en) | 2020-07-27 | 2023-03-01 | Anjarium Biosciences Ag | Compounds of DNA molecules, methods for their preparation and methods of using them |
EP4267253A1 (fr) * | 2020-12-23 | 2023-11-01 | Spark Therapeutics, Inc. | Procédés pour améliorer la thérapie génique non virale |
WO2022240806A1 (fr) * | 2021-05-11 | 2022-11-17 | Modernatx, Inc. | Administration non virale d'adn pour expression prolongée de polypeptide in vivo |
AU2022288618A1 (en) * | 2021-06-07 | 2023-12-14 | Generation Bio Co. | Apoe and apob modified lipid nanoparticle compositions and uses thereof |
WO2024079531A2 (fr) * | 2022-10-11 | 2024-04-18 | Meiragtx Uk Ii Limited | Éléments régulateurs d'acide nucléique pour l'expression génique dans le foie et procédés d'utilisation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006006561A1 (fr) * | 2004-07-12 | 2006-01-19 | Japan Science And Technology Agency | Construction d'acides nucleiques |
AU2009234266B2 (en) * | 2008-04-11 | 2015-08-06 | Tekmira Pharmaceuticals Corporation | Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components |
EP3689381A1 (fr) * | 2010-06-22 | 2020-08-05 | Onxeo | Système d'administration in vivo optimisé doté d'agents endosomolytiques pour conjugués d'acides nucléiques |
CA2989157A1 (fr) * | 2015-06-11 | 2016-12-15 | University Of Miami | Traitement et diagnostic du cancer |
JP6994140B2 (ja) * | 2016-03-03 | 2022-02-03 | ユニバーシティ オブ マサチューセッツ | 非ウイルス的遺伝子導入のための閉鎖型直鎖状二重鎖dna |
-
2020
- 2020-03-06 AU AU2020232790A patent/AU2020232790A1/en active Pending
- 2020-03-06 EP EP20766818.7A patent/EP3934700A4/fr active Pending
- 2020-03-06 WO PCT/US2020/021328 patent/WO2020181168A1/fr unknown
- 2020-03-06 US US17/435,416 patent/US20220175968A1/en active Pending
- 2020-03-06 MA MA055219A patent/MA55219A/fr unknown
- 2020-03-06 SG SG11202109426YA patent/SG11202109426YA/en unknown
- 2020-03-06 CA CA3131130A patent/CA3131130A1/fr active Pending
-
2021
- 2021-09-01 IL IL286026A patent/IL286026A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA3131130A1 (fr) | 2020-09-10 |
WO2020181168A1 (fr) | 2020-09-10 |
US20220175968A1 (en) | 2022-06-09 |
SG11202109426YA (en) | 2021-09-29 |
IL286026A (en) | 2021-10-31 |
EP3934700A4 (fr) | 2022-12-14 |
AU2020232790A1 (en) | 2021-09-16 |
EP3934700A1 (fr) | 2022-01-12 |
WO2020181168A8 (fr) | 2020-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA55219A (fr) | Nanoparticules lipidiques non actives avec adn dépourvu de capside, non viral | |
IL272799A (en) | Lipid nanoparticle formulations of non-viral capsid-free DNA vectors | |
MA52709A (fr) | Administration d'adn | |
MA40924A (fr) | Cathéter avec ensembles d'électrodes empilés | |
JP2018529501A5 (fr) | ||
DK3911354T3 (da) | AVV-formidlet genterapi, der genskaber otoferlin-genet | |
ITUB20152212A1 (it) | Telaio ripiegabile per passeggini, carrozzine e simili. | |
GB201603296D0 (en) | Chemotactic,drug-containing polymersomes | |
Sherwood et al. | Are we wired differently? | |
Alefantis et al. | Sanofi Pasteur | |
Sinha et al. | Targeted ExSeq--Tissue Preparation | |
Wallis | The So-Called Right to Try | |
Boruch | DRAWINGS | |
ഡോ. ലിസ്സി മാത്യു വി. | പത്രാധിപക്കുറിപ്പ് | |
Gaffney | 13 Sawn-off Tales | |
李玉峰 | Sonoco Product | |
JP2016222625A5 (fr) | ||
庞鑫 et al. | How to Choose a Major | |
UA40374S (uk) | Тачка будівельна | |
UA40375S (uk) | Тачка будівельна | |
*** | Marty's Birthday Gift | |
Andrä et al. | Zu den Autoren | |
Diaz Eaton | Have you heard about QUBES? | |
CL2020000451S1 (es) | Cápsula. | |
郭铃 | Récit à la voix de MARGUERITEDURAS |